Serum itraconazole concentrations and clinical responses in Candida-associated denture stomatitis patients treated with itraconazole solution and itraconazole capsules.
暂无分享,去创建一个
J. Bagg | D. Warnock | L. Cross | D. Oliver
[1] J. Bagg,et al. Evaluation of an optical instrument for objective assessment of oral mucosal erythema. , 1998, Journal of oral rehabilitation.
[2] B. Gazzard,et al. Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis. , 1997, Journal of clinical pathology.
[3] M. Ghannoum,et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] B. Gazzard,et al. Itraconazole cyclodextrin solution--effective treatment for HIV-related candidosis unresponsive to other azole therapy. , 1994, The Journal of antimicrobial chemotherapy.
[5] E. Budtz-Jörgensen. Candida-associated denture stomatitis and angular cheilitis. , 1990 .
[6] D. Warnock,et al. Comparison of high performance liquid chromatographic and microbiological methods for determination of itraconazole. , 1988, The Journal of antimicrobial chemotherapy.
[7] A. Stenderup,et al. An epidemiologic study of yeasts in elderly denture wearers. , 1975, Community dentistry and oral epidemiology.
[8] E. Budtz-Jørgensen,et al. The significance of Candida albicans in denture stomatitis , 1974 .